Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Citi
McKinsey
Medtronic
Julphar
UBS
Dow
Accenture

Generated: May 28, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074326

« Back to Dashboard

NDA 074326 describes LEVOBUNOLOL HYDROCHLORIDE, which is a drug marketed by Alcon Labs Inc, Apotex Inc, Bausch And Lomb, and Sandoz Inc, and is included in six NDAs. It is available from three suppliers. Additional details are available on the LEVOBUNOLOL HYDROCHLORIDE profile page.

The generic ingredient in LEVOBUNOLOL HYDROCHLORIDE is levobunolol hydrochloride. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.
Summary for 074326
Tradename:LEVOBUNOLOL HYDROCHLORIDE
Applicant:Bausch And Lomb
Ingredient:levobunolol hydrochloride
Patents:0
Therapeutic Class:Ophthalmic Agents
Pharmacology for NDA: 074326
Mechanism of ActionAdrenergic beta-Antagonists
Medical Subject Heading (MeSH) Categories for 074326
Suppliers and Packaging for NDA: 074326
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEVOBUNOLOL HYDROCHLORIDE levobunolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 074326 ANDA Bausch & Lomb Incorporated 24208-505 N 24208-505-05
LEVOBUNOLOL HYDROCHLORIDE levobunolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 074326 ANDA Bausch & Lomb Incorporated 24208-505 N 24208-505-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.5%
Approval Date:Mar 4, 1994TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Chubb
Dow
Fuji
Cerilliant
Baxter
Cantor Fitzgerald
Merck
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.